CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $879.95M, above the global median of $520.53M
- PositionOperating margin is 37.5%, higher than 95% of its Medical Care Facilities peers (median 11%)
- Interpretations9 currently firing — 9
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.12BUSDvs all stocks (USD)
Trailing P/E
11.92xvs Medical Care Facilities peers
Revenue (TTM)
879.95MUSDvs all stocks (USD)
Profit Margin
10.95%vs Medical Care Facilities peers
Beta
1.97xvs all stocks
52-Week Change
46.58%vs all stocks
Market Capitalization
1.12BUSDvs all stocks (USD)
Enterprise Value
1.37BUSDvs all stocks (USD)
Trailing P/E
11.92xvs Medical Care Facilities peers
Forward P/E
8.02xvs Medical Care Facilities peers
PEG Ratio
0.1506xvs Medical Care Facilities peers
Price to Sales (TTM)
1.27xvs Medical Care Facilities peers
Price to Book (MRQ)
3.27xvs Medical Care Facilities peers
Enterprise to Revenue
1.56xvs Medical Care Facilities peers
Enterprise to EBITDA
3.31xvs Medical Care Facilities peers
Gross Margin
42.37%vs Medical Care Facilities peers
Profit Margin
10.95%vs Medical Care Facilities peers
Operating Margin
37.54%vs Medical Care Facilities peers
Return on Assets (TTM)
28.59%vs Medical Care Facilities peers
Return on Equity (TTM)
53.65%vs Medical Care Facilities peers
Revenue (TTM)
879.95MUSDvs all stocks (USD)
Revenue per Share (TTM)
131.49USDUpdated Jul 19, 2026Quarterly Revenue Growth
2.20%vs Medical Care Facilities peers
Gross Profit (TTM)
445.10MUSDvs all stocks (USD)
EBITDA (TTM)
291.84MUSDvs all stocks (USD)
Net Income (TTM)
96.38MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
120.60%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
272.68MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
168.75MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
93.99MUSDFY2025 · Dec 31, 2025Revenue
875.26MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
430.98MUSDFY2025 · Dec 31, 2025Gross Profit
444.28MUSDFY2025 · Dec 31, 2025Operating Income
275.63MUSDvs all stocks (USD)
Pre-tax Income
244.78MUSDFY2025 · Dec 31, 2025Income Tax Expense
64.42MUSDFY2025 · Dec 31, 2025Net Income
180.36MUSDFY2025 · Dec 31, 2025EBIT
267.01MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
287.54MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
168.66MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
22.23MUSDFY2025 · Dec 31, 2025EPS (Basic)
11.13USDFY2025 · Dec 31, 2025EPS (Diluted)
10.48USDFY2025 · Dec 31, 2025Basic Shares Outstanding
6.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
6.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
180.36MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-109.57MUSDFY2025 · Dec 31, 2025Operating Cash Flow
284.80MUSDFY2025 · Dec 31, 2025Free Cash Flow
282.27MUSDDerived from operating cash flow minus capital expenditure. This filing charges 20.53M of depreciation against 2.53M of capital expenditure, and its own free-cash-flow line reads 245.6M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
185.87MUSDFY2025 · Dec 31, 2025Income Tax Paid
72.81MUSDFY2025 · Dec 31, 2025Interest Paid
2.51MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
180.36MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
20.53MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
17.08MUSDFY2025 · Dec 31, 2025Stock-based Compensation
117.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
902.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-89.32MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
37.85MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
393.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-2.53MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Sale of Investments
1.60MUSDFY2025 · Dec 31, 2025Other Investing Activity
-4.31MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-5.24MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
5.04MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-24.48MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-5.00MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-74.28MUSDFY2025 · Dec 31, 2025Other Financing Charges
767.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-97.95MUSDFY2025 · Dec 31, 2025Shares Outstanding
6.95MSharesUpdated Jul 19, 2026Float Shares
4.22MSharesUpdated Jul 19, 2026Shares Short
1.11MSharesUpdated Jul 19, 2026Short Ratio
8.53daysvs all stocks
Short % of Shares Outstanding
25.42%vs all stocks
% Held by Insiders
29.06%vs all stocks
% Held by Institutions
42.53%vs all stocks
Total Cash (MRQ)
207.35MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
30.13USDUpdated Jul 19, 2026Total Debt (MRQ)
349.09MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7897xvs Medical Care Facilities peers
Current Ratio (MRQ)
3.14xvs Medical Care Facilities peers
Book Value per Share (MRQ)
49.81USDUpdated Jul 19, 2026Total Assets
918.52MUSDvs all stocks (USD)
Total Current Assets
538.81MUSDFY2025 · Dec 31, 2025Total Liabilities
495.09MUSDFY2025 · Dec 31, 2025Total Non-current Assets
379.71MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
337.18MUSDFY2025 · Dec 31, 2025Total Current Liabilities
157.91MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
185.57MUSDFY2025 · Dec 31, 2025Accounts Receivable
325.42MUSDFY2025 · Dec 31, 2025Inventory
2.87MUSDFY2025 · Dec 31, 2025Accounts Payable
48.97MUSDFY2025 · Dec 31, 2025Short-term Debt
23.30MUSDFY2025 · Dec 31, 2025Long-term Debt
328.09MUSDFY2025 · Dec 31, 2025Common Stock (Book)
7.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-286.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
423.44MUSDvs all stocks (USD)
52-Week Low
77.21USDUpdated Jul 19, 202652-Week High
204.00USDUpdated Jul 19, 202652-Week Change
46.58%vs all stocks
Beta
1.97xvs all stocks
50-Day MA
146.78USDUpdated Jul 19, 2026200-Day MA
130.24USDUpdated Jul 19, 2026Avg 10-Day Volume
109.38KSharesUpdated Jul 19, 2026Avg 30-Day Volume
127.72KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
13.67USDUpdated Jul 19, 2026Other Income / Expense
-8.62MUSDFY2025 · Dec 31, 20259 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Elevated Receivables Alongside Balance-Sheet Strength
Liquidity looks comfortable, but it rests on customer debts that have grown three years.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
SBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)
Pay in shares is large next to its revenue and its profit, and the share count keeps rising.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 37.5%, higher than 95% of its Medical Care Facilities peers (median 11%)Significant
Operating margin: 0.38Industry median: 0.11Industry P95: 0.26Peers compared: 70.00
Return on equity is 53.6%, higher than 95% of its Medical Care Facilities peers (median 10.7%)Significant
Return on equity: 0.54Industry median: 0.11Industry P95: 0.42Peers compared: 70.00
Return on assets is 28.6%, higher than 95% of its Medical Care Facilities peers (median 5.6%)Significant
Return on assets: 0.29Industry median: 0.06Industry P95: 0.17Peers compared: 70.00
Financial Health
Altman Z-Score 3.33: safe zoneNotable
Altman Z-Score: 3.33
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $879.95M, above the global median of $520.53MNotable
Revenue (USD): 879,953,024Global Median: 520,528,949.311
Levered free cash flow is $168.75M, above the global median of $16.24MNotable
Levered free cash flow (USD): 168,750,624Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Tobii Dynavox AB
Tier 1ProductionThroughput-Bound ConversionRule
Shenzhen AV-Display Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Aladdin Biochemical Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Hd Hyundai Energy Solutions Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Suzhou Shijia Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Zhejiang Asia-Pacific Mechanical & Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kingsignal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Seagull Cooling Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
U.S. Physical Therapy Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Longwell Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Euroseas Ltd.
6 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthLiquidity Ratios Elevated
Gürsel Turizm Taşımacılık Ve Ticaret A.Ş.
6 interpretationsFCF Ratios ElevatedReceivables Heavy and GrowingROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue Growth
One Career Inc.
6 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthLiquidity Ratios Elevated